Cyclosporine in Treating Patients With Recurrent or Refractory Angioimmunoblastic T-Cell Lymphoma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Ranjana Advani, MD
Stanford University
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
23 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Stanford Cancer Center
Stanford, California, United States
- Rush-Copley Cancer Care Center
Aurora, Illinois, United States
- Hematology Oncology Associates of Illinois - Berwyn
Berwyn, Illinois, United States
- Hematology and Oncology Associates
Chicago, Illinois, United States
- Robert H. Lurie Comprehensive Cancer Center at Northwestern University
Chicago, Illinois, United States
- Saint Joseph Hospital
Chicago, Illinois, United States
- Joliet Oncology-Hematology Associates, Limited - West
Joliet, Illinois, United States
- Midwest Center for Hematology/oncology
Joliet, Illinois, United States
- North Shore Oncology and Hematology Associates, Limited - Libertyville
Libertyville, Illinois, United States
- la Grange Oncology Associates - Geneva
Naperville, Illinois, United States
- Cancer Care and Hematology Specialists of Chicagoland - Niles
Niles, Illinois, United States
- Hematology Oncology Associates - Skokie
Skokie, Illinois, United States
- Ccop - Carle Cancer Center
Urbana, Illinois, United States
- Carle Cancer Center at Carle Foundation Hospital
Urbana, Illinois, United States
- Saint Anthony Memorial Health Centers
Michigan City, Indiana, United States
- Mercy Medical Center - Sioux City
Sioux City, Iowa, United States
- Siouxland Hematology-Oncology Associates, Llp
Sioux City, Iowa, United States
- St. Luke'S Regional Medical Center
Sioux City, Iowa, United States
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Baltimore, Maryland, United States
- Borgess Medical Center
Kalamazoo, Michigan, United States
- Bronson Methodist Hospital
Kalamazoo, Michigan, United States
- West Michigan Cancer Center
Kalamazoo, Michigan, United States
- St. Rita'S Medical Center
Lima, Ohio, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 24 Jan 2006
- Primary completion
- 31 Mar 2009
- Completion
- 31 May 2011
- Last update posted
- 29 Jun 2023
- Registered enrollment
- 4
- Registry id
- NCT00070291
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.